DK582083A - 4,7-dihydropyrazol(3,4-b)pyridin-5-karboxylsyrederivater - Google Patents

4,7-dihydropyrazol(3,4-b)pyridin-5-karboxylsyrederivater Download PDF

Info

Publication number
DK582083A
DK582083A DK582083A DK582083A DK582083A DK 582083 A DK582083 A DK 582083A DK 582083 A DK582083 A DK 582083A DK 582083 A DK582083 A DK 582083A DK 582083 A DK582083 A DK 582083A
Authority
DK
Denmark
Prior art keywords
karboxylsyrederivater
dihydropyrazole
pyridine
antiangina
vasodilating
Prior art date
Application number
DK582083A
Other languages
Danish (da)
English (en)
Other versions
DK582083D0 (da
Inventor
Giorgio Winters
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Publication of DK582083D0 publication Critical patent/DK582083D0/da
Publication of DK582083A publication Critical patent/DK582083A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DK582083A 1982-12-20 1983-12-16 4,7-dihydropyrazol(3,4-b)pyridin-5-karboxylsyrederivater DK582083A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8236131 1982-12-20

Publications (2)

Publication Number Publication Date
DK582083D0 DK582083D0 (da) 1983-12-16
DK582083A true DK582083A (da) 1984-06-21

Family

ID=10535093

Family Applications (1)

Application Number Title Priority Date Filing Date
DK582083A DK582083A (da) 1982-12-20 1983-12-16 4,7-dihydropyrazol(3,4-b)pyridin-5-karboxylsyrederivater

Country Status (19)

Country Link
US (1) US4954508A (ja)
EP (1) EP0114273B1 (ja)
JP (1) JPH0660181B2 (ja)
KR (1) KR890002227B1 (ja)
AT (1) ATE69227T1 (ja)
AU (1) AU574654B2 (ja)
DE (1) DE3382452D1 (ja)
DK (1) DK582083A (ja)
ES (2) ES8601987A1 (ja)
FI (1) FI76337C (ja)
GR (1) GR79111B (ja)
IE (1) IE57305B1 (ja)
IL (1) IL70445A (ja)
MY (1) MY101250A (ja)
NO (1) NO160367C (ja)
NZ (1) NZ206626A (ja)
PH (1) PH20896A (ja)
PT (1) PT77850B (ja)
ZA (1) ZA839092B (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5965089A (ja) * 1982-10-05 1984-04-13 Shionogi & Co Ltd ジヒドロピラゾロ〔３，４−ｂ〕ピリジン誘導体およびその製造法
US4873334A (en) * 1982-10-05 1989-10-10 Shionogi & Co., Ltd. 4,7-dihydropyrazolo(3,4-b) pyridine derivatives
JPS60197685A (ja) * 1984-03-19 1985-10-07 Shionogi & Co Ltd ４，７―ジヒドロピラゾロ［３，４―ｂ］ピリジン誘導体とその製造法
JPS6056979A (ja) * 1983-09-08 1985-04-02 Shionogi & Co Ltd ４，７−ジヒドロピラゾロ〔３，４−ｂ〕ピリジン誘導体およびその製造法
US4918074A (en) * 1984-03-12 1990-04-17 Yoshitomi Pharmaceutical Industries, Ltd. Polyazaheterocycle compounds
US4916140A (en) * 1988-09-28 1990-04-10 Merrell Dow Pharmaceuticals Inc. Antiepileptic pyrazolopyridines
WO2002062795A2 (en) * 2001-02-02 2002-08-15 Mitsubishi Pharma Corporation Dihydropyrazolopyridine compounds and pharmaceutical use thereof
US6977262B2 (en) 2001-02-02 2005-12-20 Mitsubishi Pharma Corporation Dihydropyrazolopyridine compounds and pharmaceutical use thereof
CN1823067A (zh) * 2003-06-13 2006-08-23 赞塔里斯有限公司 具有抑制磷脂酰肌醇3－激酶活性的化合物及其使用方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773778A (en) * 1972-01-24 1973-11-20 Squibb & Sons Inc Sulfur derivatives of pyrazolo (3,4-b)pyridines
DE2356684A1 (de) * 1972-11-15 1974-05-16 Heyden Chem Fab Neue 4-aminoderivate von pyrazolo (3,4-b)pyridin-5-carboxamiden
US4038283A (en) * 1975-04-30 1977-07-26 E. R. Squibb & Sons, Inc. 4-Alkoxy or hydroxy derivatives of 2H-pyrazolo[3,4-b]pyridine-5-carboxylic acids and esters
GB1568399A (en) * 1975-10-16 1980-05-29 Squibb & Sons Inc Pyrazolo pyridine derivatives
US4020072A (en) * 1976-05-04 1977-04-26 E. R. Squibb & Sons, Inc. 5-Aminomethyl-1H-pyrazolo[3,4-b]pyridines
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
JPS5965089A (ja) * 1982-10-05 1984-04-13 Shionogi & Co Ltd ジヒドロピラゾロ〔３，４−ｂ〕ピリジン誘導体およびその製造法

Also Published As

Publication number Publication date
PH20896A (en) 1987-05-27
IL70445A (en) 1988-12-30
NO160367C (no) 1989-04-12
PT77850A (en) 1984-01-01
IE57305B1 (en) 1992-07-15
EP0114273A1 (en) 1984-08-01
ES8506016A1 (es) 1985-06-16
IL70445A0 (en) 1984-03-30
DK582083D0 (da) 1983-12-16
NO834695L (no) 1984-06-21
ES528152A0 (es) 1985-11-16
FI834661A (fi) 1984-06-21
JPH0660181B2 (ja) 1994-08-10
ATE69227T1 (de) 1991-11-15
NZ206626A (en) 1986-11-12
ES8601987A1 (es) 1985-11-16
JPS59118786A (ja) 1984-07-09
ZA839092B (en) 1984-07-25
FI76337B (fi) 1988-06-30
EP0114273B1 (en) 1991-11-06
KR890002227B1 (ko) 1989-06-24
FI76337C (fi) 1988-10-10
FI834661A0 (fi) 1983-12-19
KR840007000A (ko) 1984-12-04
DE3382452D1 (de) 1991-12-12
NO160367B (no) 1989-01-02
PT77850B (en) 1986-05-08
US4954508A (en) 1990-09-04
AU2227083A (en) 1984-06-28
AU574654B2 (en) 1988-07-14
MY101250A (en) 1991-08-17
IE832988L (en) 1984-06-20
GR79111B (ja) 1984-10-02
ES532124A0 (es) 1985-06-16

Similar Documents

Publication Publication Date Title
ZA839693B (en) Substituted 4-aminomethylene-chromans and-chromens,processes for their preparation and their use in medicaments
DE3366494D1 (de) New 6-substituted-s-triazolo(3,4-a)phthalazine derivatives
DK173883D0 (da) Substituerede 8-phenylxanthiner
IL64292A (en) D-homoandrostane-17alpha-carboxylic acids,derivatives thereof and 17alpha-spiroethers,their manufacture and pharmaceutical compositions containing them
EP0104522A3 (en) New pyrazolo(3,4-b)pyridine derivatives and process for producing them
IL58299A (en) Fluorine-containing 1,4-dihydropyridine derivatives,their production and their medicinal use
IL66496A0 (en) Sulfur-substituted phenoxypyridines having antiviral activity,process for their production and pharmaceutical compositions containing them
DK582083A (da) 4,7-dihydropyrazol(3,4-b)pyridin-5-karboxylsyrederivater
EP0249249A3 (en) Glycerol derivatives
DE3170356D1 (en) Novel aldehyde adducts of triamterene and a pharmaceutical composition containing the same
CA1262912C (en) TETRAHYDROFURANYLIC SUBSTITUTION DERIVATIVES OF PROSTAGLANDIN ANALOGS
CA1268468C (en) PROSTAGLANDIN ANALOGS WITH SUBSTITUTE THIABICYCLOHEPTAN GROUP
EP0319130A3 (en) Process for the preparation of ascorbic acid-2-phosphate
ES8504776A1 (es) Un metodo para preparar compuestos de fenilpiperazina sustituidos
SE8401916D0 (sv) Condensed benzopyrone derivatives

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment